DOI: 10.53941/ijddp.2026.100017 ISSN: 2653-6234

Distinct Sex-Specific Characteristics of Apoe Deficient and Ldlr Deficient Mice in Atherosclerosis: Implications for Model Selection and Therapy Development

Yaping Zhao, Li Wang, Bradford C. Berk, Hans Strijdom, Yu Huang, Jianping Weng, Suowen Xu

The progression of cardiovascular disease shows significant sexual dimorphism: although females generally develop the disease later in life, they exhibit a higher age-related incidence than males. While current studies have separately reported sex differences in atherosclerotic development in Apoe−/− and Ldlr−/−, a comparative assessment of these sex-specific characteristics across both models is lacking. This study therefore aimed to assess the influence of sex on atherosclerosis using both Apoe−/− and Ldlr−/− mice. Eight-week-old mice were fed an atherogenic ALMN diet for 20 weeks to promote plaque development. We performed comprehensive analyses of: (1) systemic metabolic parameters (lipid profile, glucose metabolism); (2) atherosclerotic burden (whole aorta and aortic sinus plaque area); and (3) plaque composition (necrotic core size, collagen content, macrophage infiltration) in mice of both sexes. As a result, male mice showed higher lipid levels, worse glucose tolerance, and reduced insulin sensitivity compared to females in both models. Apoe−/− mice showed minimal sex differences in atherosclerosis with a trend toward increased plaque size in females. Plaque composition did not differ significantly between sexes in Apoe−/− mice. In contrast, Ldlr−/− males exhibited greater whole aortic plaque burden than females, yet plaque stability also remained similar across sexes. This comparative analysis of two widely used murine atherosclerosis models reveals genotype-dependent sexual dimorphism. This study underscores the importance of considering the distinct sex-specific characteristics of Apoe−/− and Ldlr−/− mice when selecting animal models for exploring atherosclerosis pathomechanisms as well as effective pharmacotherapies, and further supports the necessity of developing sex-specific therapies.

More from our Archive